Name | N-[5-[[5-(2-cyanoethylcarbamoyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-4-formamido-1-methylpyrrole-2-carboxamide |
---|---|
Synonyms |
N-(5,6-dimethylbenzothiazol-2-yl)salicylamide
N-(5,6-Dimethyl-2-benzothiazolyl)-2-hydroxybenzamide Benzamide,N-(5,6-dimethyl-2-benzothiazolyl)-2-hydroxy N-(5-{[(5-{[(2-cyanoethyl)amino]carbonyl}-1-methyl-1H-pyrrol-3-yl)amino]carbonyl}-1-methyl-1H-pyrrol-3-yl)-4-(formylamino)-1-methyl-1H-pyrrole-2-carboxamide |
Density | 1.38g/cm3 |
---|---|
Boiling Point | 700.2ºC at 760 mmHg |
Molecular Formula | C22H24N8O4 |
Molecular Weight | 464.47700 |
Flash Point | 377.3ºC |
Exact Mass | 464.19200 |
PSA | 158.47000 |
LogP | 2.60488 |
Index of Refraction | 1.669 |
~88% 71084-59-8 |
Literature: Beria, Italo; Baraldi, Pier Giovanni; Cozzi, Paolo; Caldarelli, Marina; Geroni, Cristina; Marchini, Sergio; Mongelli, Nicola; Romagnoli, Romeo Journal of Medicinal Chemistry, 2004 , vol. 47, # 10 p. 2611 - 2623 |
~% 71084-59-8 |
Literature: NAXOSPHARMA S.R.L. Patent: WO2004/106301 A1, 2004 ; Location in patent: Page 15 ; |
Precursor 2 | |
---|---|
DownStream 0 |